Skip to main content
    • Aa
    • Aa
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 19
  • Cited by
    This article has been cited by the following publications. This list is generated based on data provided by CrossRef.

    Hartl, Dana M. and Brasnu, Daniel F. 2015. Contemporary Surgical Management of Early Glottic Cancer. Otolaryngologic Clinics of North America, Vol. 48, Issue. 4, p. 611.

    Geryk, Edvard Štampach, Radim Dítě, Petr Kozel, Jiří Horváth, Teodor and Kubíček, Petr 2013. Clinical Stages in Patients with Primary and Subsequent Cancers Based on the Czech Cancer Registry 1976–2005. ISRN Oncology, Vol. 2013, p. 1.

    Atienza, Jonessa Ann S. and Dasanu, Constantin A. 2012. Incidence of second primary malignancies in patients with treated head and neck cancer: a comprehensive review of literature. Current Medical Research and Opinion, Vol. 28, Issue. 12, p. 1899.

    Hartl, Dana M. 2012. Evidence-Based Practice. Otolaryngologic Clinics of North America, Vol. 45, Issue. 5, p. 1143.

    Bradley, Patrick J and Bradley, Paula T 2010. Searching for metachronous tumours in patients with head and neck cancer: the ideal protocol!. Current Opinion in Otolaryngology & Head and Neck Surgery, Vol. 18, Issue. 2, p. 124.

    Hoffman, Henry T. Iseli, Tim A. Karnell, Lucy H. McCulloch, Timothy M. Buatti, John M. and Funk, Gerry F. 2010. Cummings Otolaryngology - Head and Neck Surgery.

    Rosenthal, David I. Fuller, Clifton D. Barker, Jerry L. Mason, Bryan Garcia, John A. Lewin, Jan S. Holsinger, F. Christopher Stasney, C. Richard Frank, Steven J. Schwartz, David L. Morrison, William H. Garden, Adam S. and Ang, K. Kian 2010. Simple Carotid-Sparing Intensity-Modulated Radiotherapy Technique and Preliminary Experience for T1–2 Glottic Cancer. International Journal of Radiation Oncology*Biology*Physics, Vol. 77, Issue. 2, p. 455.

    Bertrand, D. Righini, C. Ferretti, G. Brambilla, C. and Moro-Sibilot, D. 2008. Diagnostic précoce du cancer bronchique après cancer « tête et cou ». Revue des Maladies Respiratoires, Vol. 25, Issue. 5, p. 559.

    Sjögren, Elisabeth V. Snijder, Simone van Beekum, Joost and Baatenburg de Jong, Robert Jan 2006. Second malignant neoplasia in early (TIS-T1) glottic carcinoma. Head & Neck, Vol. 28, Issue. 6, p. 501.

    Gal, Thomas J. Huang, Wen-Yi Chen, Chu Hayes, Richard B. and Schwartz, Stephen M. 2005. DNA Repair Gene Polymorphisms and Risk of Second Primary Neoplasms and Mortality in Oral Cancer Patients. The Laryngoscope, Vol. 115, Issue. 12, p. 2221.

    León, Xavier Prado Venegas, María Orús, César Kolañczak, Kasia García, Jacinto and Quer, Miquel 2005. Metachronous second primary tumours in the aerodigestive tract in patients with early stage head and neck squamous cell carcinomas. European Archives of Oto-Rhino-Laryngology, Vol. 262, Issue. 11, p. 905.

    Nix, P Cawkwell, L Patmore, H Greenman, J and Stafford, N 2005. Bcl-2 expression predicts radiotherapy failure in laryngeal cancer. British Journal of Cancer, Vol. 92, Issue. 12, p. 2185.

    Colasanto, Joseph M. Haffty, Bruce G. and Wilson, Lynn D. 2004. Evaluation of Local Recurrence and Second Malignancy in Patients with T1 and T2 Squamous Cell Carcinoma of the Larynx. The Cancer Journal, Vol. 10, Issue. 1, p. 61.

    Horvath, T.A Hirano, T Horvathova, M.D Vomela, J Vyzula, R Čı́halová, M Dorociak, F Ebihara, Y Furukawa, K Habanec, B Ikeda, N Kakihana, M Klusáková, J Okada, S Rejthar, A Stratil, D Shaffi-Sahely, A Šmajer, B Špelda, S Tsuboi, M Vagunda, V Wurst, F and Kato, H 2004. Autofluorescence (safe) bronchoscopy and p21/ki-67 immunostaining related to carcinogenesis. Photodiagnosis and Photodynamic Therapy, Vol. 1, Issue. 1, p. 13.

    Nix, P.A. Greenman, J. Cawkwell, L. and Stafford, N. 2004. Radioresistant laryngeal cancer: beyond the TNM stage. Clinical Otolaryngology and Allied Sciences, Vol. 29, Issue. 2, p. 105.

    Nix, P.A. Greenman, J. Cawkwell, L. and Stafford, N.D. 2004. Defining the criteria for radioresistant laryngeal cancer. Clinical Otolaryngology and Allied Sciences, Vol. 29, Issue. 6, p. 705.

    THARIAT, J BRUCHON, Y BONNETAIN, F BARILLOT, I TRUC, G PEIGNAUX, K HORIOT, J and MAINGON, P 2004. Conservative treatment of early glottic carcinomas with exclusive radiotherapy. Cancer/Radiothérapie, Vol. 8, Issue. 5, p. 288.

    Zeng, Haishan McWilliams, Annette and Lam, Stephen 2004. Optical spectroscopy and imaging for early lung cancer detection: a review. Photodiagnosis and Photodynamic Therapy, Vol. 1, Issue. 2, p. 111.

    Sankaranarayanan, R Ramanakumar, Agnihotram V and Yeole, Balakrishna B 2003. Survival from glottic and supraglottic laryngeal carcinoma in Mumbai (Bombay), India. Oral Oncology, Vol. 39, Issue. 7, p. 656.


Second malignancies in early stage laryngeal carcinoma patients treated with radiotherapy

  • John M. Holland (a1), Amir Arsanjani (a1), Benny J. Liem (a1), S. Christopher Hoffelt (a1), James I. Cohen (a2) and Kenneth R. Stevens (a1)
  • DOI:
  • Published online: 01 March 2002

A retrospective review of 240 patients with T1/T2 squamous cell carcinomas of the larynx was performed. Seventy-two per cent had glottic primaries, 27 per cent had supraglottic tumours and one per cent had subglottic disease. Sixty-nine per cent presented with T1 disease and 31 per cent had T2 staged tumours. All patients were treated with definitive radiotherapy between 1973 and 1997.

With a median follow-up of 68 months, 68 patients (28 per cent) have developed 72 other cancers. Ten of 68 presented with synchronous primaries (15 per cent). Thirty per cent of glottic patients and 25 per cent of the supraglottic/subglottic patients developed second cancers. The most frequent second malignancy was lung cancer: 28/72 (39 per cent). Fifteen patients developed second head and neck cancers (21 per cent). Other second primary sites included oesophagus (eight), prostate (six), colorectal (five), breast (two) and others (eight). The median time from radiotherapy until the development of a second cancer was 31 months. The Kaplan-Meier survival estimate at five years was significantly less for those patients developing second cancers (55 per cent) compared to those not developing second malignancies (70 per cent), (p<0.05). The median survival from the development of a second cancer was 14 months. More died as a result of a second cancer (41 patients) than their primary laryngeal cancer (40 patients). Second cancers are common and deadly in patients with early stage laryngeal carcinoma.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

The Journal of Laryngology & Otology
  • ISSN: 0022-2151
  • EISSN: 1748-5460
  • URL: /core/journals/journal-of-laryngology-and-otology
Please enter your name
Please enter a valid email address
Who would you like to send this to? *